Alterity Therapeutics (Alterity Therapeutics) FCF Yield % : -31.40 (As of May. 04, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Alterity Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Alterity Therapeutics's Trailing 12-Month Free Cash Flow is $-5.51 Mil, and Market Cap is $17.90 Mil. Therefore, Alterity Therapeutics's FCF Yield % for today is -31.40%.

The historical rank and industry rank for Alterity Therapeutics's FCF Yield % or its related term are showing as below:

ATHE' s FCF Yield % Range Over the Past 10 Years
Min: -791.91 Med: -63.35 Max: -1.88
Current: -31.4

During the past 13 years, the highest FCF Yield % of Alterity Therapeutics was -1.88%. The lowest was -791.91%. And the median was -63.35%.

ATHE's FCF Yield % is ranked worse than
67.35% of 1553 companies
in the Biotechnology industry
Industry Median: -14.39 vs ATHE: -31.40

Alterity Therapeutics's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

Alterity Therapeutics FCF Yield % Historical Data

The historical data trend for Alterity Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics FCF Yield % Chart

Alterity Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-51.59

-31.69

-29.36

-35.62

-118.47

Alterity Therapeutics Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Alterity Therapeutics's FCF Yield %

For the Biotechnology subindustry, Alterity Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alterity Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's FCF Yield % falls into.

Alterity Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Alterity Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-13.452	/	11.3544813
	=	-118.47%

Alterity Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.35	*	4	/	0
	=	N/A%

Alterity Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Alterity Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterity Therapeutics (Alterity Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (NAS:ATHE) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

PBN:Germany ATH:Australia

Address

350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.alteritytherapeutics.com

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.